MedPath

Effect of N-acetyl Cysteine (NAC) on contrast-induced nephropathy in patients with basal urinary neutrophil gelatinase-associated lipocalin (NGAL) positive underwent angiography or coronary intervention (PCI): A single blind randomized clinical trial

Phase 3
Recruiting
Conditions
Contrast- Induced Nephropathy disease.
Other acute kidney failure
Registration Number
IRCT20190311043011N1
Lead Sponsor
Hamedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
110
Inclusion Criteria

Age 18 to 90 years
Undergoing angiography or coronary artery intervention

Exclusion Criteria

Kidney disease
Urinary tract infection
Urinary tract tumor
Use of Nephrotoxic or Antibiotic drugs or contrast media within past week

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serum creatinine. Timepoint: Before and 48 hours after the intervention. Method of measurement: blood test.;Neutrophil Gelatinase Associated Lipocalin. Timepoint: Before the intervention. Method of measurement: Urine Test.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath